248 related articles for article (PubMed ID: 9634572)
21. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
[TBL] [Abstract][Full Text] [Related]
22. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
West AR; Grace AA
J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
[TBL] [Abstract][Full Text] [Related]
23. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
24. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo.
West AR; Grace AA
J Neurophysiol; 2000 Apr; 83(4):1796-808. PubMed ID: 10758092
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux.
Nissbrandt H; Elverfors A; Engberg G
Synapse; 1994 Aug; 17(4):217-24. PubMed ID: 7992197
[TBL] [Abstract][Full Text] [Related]
26. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.
Sarre S; Vandeneede D; Ebinger G; Michotte Y
J Neurochem; 1998 Apr; 70(4):1730-9. PubMed ID: 9523592
[TBL] [Abstract][Full Text] [Related]
28. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
29. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
30. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats.
Grimm JW; See RE
Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113
[TBL] [Abstract][Full Text] [Related]
31. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
Olds ME
Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
[TBL] [Abstract][Full Text] [Related]
32. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
Gill KM; Cook JM; Poe MM; Grace AA
Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
[TBL] [Abstract][Full Text] [Related]
33. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
See RE; Murray CE
Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
35. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
Lucas G; Spampinato U
J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521
[TBL] [Abstract][Full Text] [Related]
36. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
Bruggeman R; Westerink BH; Timmerman W
Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors.
Erhardt S; Andersson B; Nissbrandt H; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):611-9. PubMed ID: 9686936
[TBL] [Abstract][Full Text] [Related]
38. Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.
Katagiri N; Abe K; Kitabatake M; Utsunomiya I; Horiguchi Y; Hoshi K; Taguchi K
Neuroscience; 2009 Jun; 160(4):820-8. PubMed ID: 19285542
[TBL] [Abstract][Full Text] [Related]
39. Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens.
Onn SP; Grace AA
J Neurosci; 1995 Nov; 15(11):7024-36. PubMed ID: 7472458
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
